ArticleNucleic acids research2026
Structural and enzymatic insights into QatD, a dual-function TatD-like nuclease in the QatABCD anti-phage defense system.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The qatABCD system is a widespread anti-phage module featuring a core QatBC complex, but the specific biological role of its conserved component, QatD, has long been enigmatic. Here, we establish QatD is a TatD-family nuclease co-opted for antiviral defense. The crystal structure of Acinetobacter baumannii QatD reveals a classic TIM-barrel fold featuring a conserved "HxH" active-site motif characteristic of Type II TatD enzymes. Biochemically, QatD exhibits metal-dependent dual activity: a Mg2+-dependent 3'-5' exonuclease and a Ca2+-dependent apurinic/apyrimidinic (AP) endonuclease. We further demonstrate that QatD confers resistance against diverse bacteriophages in vivo, suggesting its defense function is tied to its catalytic activity. Crucially, we discovered that the nuclease activity of QatD is tightly inhibited by physiological concentrations of host nucleoside triphosphates (NTPs). Based on these findings, we propose a mechanistic model wherein the massive nucleotide consumption during rapid viral transcription and replication depletes local host NTP pools, thereby relieving the metabolic inhibition on QatD. The unleashed QatD subsequently targets and degrades single-stranded replication intermediates and AP-site-containing viral genomes. Our work not only elucidates the molecular basis of QatD activation but also highlights an elegant evolutionary strategy wherein bacteria couple metabolic sensing with ancient DNA repair machinery for specialized immune defense.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.